Power Law company profile

Acceleron Pharma

Biotech & Life Sciences · Cambridge, United States · Founded 2004 · IPO 2013 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$11B

Market cap · 2026

Revenue

$201M

Latest reported FY

Investors

10 investors on Acceleron Pharma's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

Sutter Hill Ventures

Series B+ 9 investors entered at this stage

OrbiMed

Celgene

Advanced Technology Ventures

Bessemer Venture Partners

Global footprint

Where Acceleron Pharma has talent and traffic

Web traffic by country

50 monthly visits
across markets

🇺🇸 United States0%

Top 1 markets shown

Patent intelligence

$309M patent portfolio · 108 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$309M

2.8% of market cap · 34.3× the top peer Transcenta ($9M)

108 active patent families

Where Acceleron Pharma innovates AntagonistDiseaseMolecular biologyPharmacologyCell biology

Below peer median on Legal, Market, Economic, Technology

Quality vs same-sector peers

Acceleron Pharma on the five Patsnap quality dimensions

Acceleron Pharma in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Acceleron Pharma concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Acceleron Pharma and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Acceleron Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo